medigraphic.com
ISSN 1684-1824 (Electronic)

2013, Number 1

<< Back Next >>

Rev Méd Electrón 2013; 35 (1)

Central insipid diabetes: presentation of a case

Delgado FMR, Romero ROL, Díaz BA

Language: Spanish
References: 15
Page: 45-51
PDF size: 37.66 Kb.


ABSTRACT

The central insipid diabetes is an entity characterized by the incapacity of concentrating urine secondary to a total or partial deficiency in the dehydrogenase alcohol release. There several causes; in pediatrics, the tumors of hypothalamic hypophyseal region, and also the histiocytosis count for most of the cases of the clinical practice. The disease onset is abrupt. Polyuria and polydipsia are the predominant clinical expression in answer to the patient incapacity of maintaining the hydric balance. It is necessary to make a balance of inputs and outputs and also to determine the urinary density for arriving to the disease diagnosis. When there is an established diagnose, complementary studies should be made to determine the etiology. The treatment of the insipid diabetes is aimed to avoid the polyuria, for what demopresine is used. The purpose of our work was demonstrating the clinical characteristics of a patient diagnosed with insipid diabetes and treated at the Endocrinology service of the Teaching Provincial Pediatric Hospital Eliseo Noel Caamaño, in 2010.


REFERENCES

  1. Maghnie M, Cosi G, Genovese E, Manca-Bitti ML, Cohen A, Zecca S, et al. Central diabetes insipidus in children and young adults. N Engl J Med. 2006;343:998-1007. Citado en PubMed; PMID: 11018166.

  2. Scherbaum WA, Wass JA, Besser GM, Bottazzo GF, Doniach D. Autoimmune cranial diabetes insipidus: its association with other endocrine diseases and with histiocytosis X. Clin Endocrinol (Oxf). 1986;25(4):411-20. Citado en PubMed; PMID: 3497738.

  3. Hashimoto K, Asaba K, Tamura K, Takao T, Nakamura T. A case of Iymphocytic infundibuloneurohypophysitis associated with systemic lupus erythematosus. Endocr J. 2002;49(6):605-10. Citado en PubMed; PMID: 12625409.

  4. Imai H, Okuyama S, Komatsuda A, Wakui H, Miura AB. Central diabetes insipidus due to lymphocytic infundibuloneurohypophysitis. Am J Med. 2000;109(6):497-9. Citado en PubMed; PMID: 11042242.

  5. Panicker HK, Janicic N, Nguyen D, Verbalis J. Presumed infundibuloneurohypophysitis: unusual presentation in a postpartum patient. Am J Neuroradiol. 2005;26(2):357-9. Citado en PubMed; PMID: 15709135.

  6. Kanou Y, Arita K, Kurisu K, Tominaga A, Akimitsu T. Infundibuloneurohypophysitis presenting a large sellarjuxtasellar mass: case report. Surg Neurol. 2004;61(3):278-81. Citado en PubMed; PMID: 14985002.

  7. Amagasa M, Yuda F, Kojima H, Noshita N, Sato S. Natural course of lymphocytic infundibuloneurohypophysitis. Clin Neuropathol. 2001;20(5):229-329. Citado en PubMed; PMID: 11594509.

  8. Takao T, Asaba K, Tanaka H, Matsumoto R, Nanamiya W, Hashimoto K. A case of Iymphocytic infundibuloneurohypophysitis showing diabetes insipidus followed by anterior hypopituitarism associated with thrombasthenia. Endocr J. 2000;47(3):285-91. Citado en PubMed; PMID: 11036872.

  9. The Diabetes Inspidus Foundation. What is NDI?; 2006. Disponible en: http://www.diabetesinsipidus.org/4_types_nephrogenic_di.htm.

  10. Kapur P, Erickson C, Rakheja D, Carder K, Hoang M. Congenital self-healing reticulohistiocytosis (Hashimoto-Pritzker disease): ten-year experience at Dallas Children's Medical Center. J Am Acad Dermatol. 2007;56(2):290-4. Citado en PubMed; PMID: 17224372.

  11. Ginhoux F, Tacke F, Angeli V, Bogunovic M, Loubeau M, Dai XM, et al. Langerhans cells arise from monocytes in vivo. Nat Immunol. 2006; 7 (3):265–73. Citado en PubMed; PMID: 16444257.

  12. Walid MS, Grigorian AA. Ethmo-spheno-intracranial Rosai-Dorfman disease. Indian J Cancer 2010;47(1):80-1. Citado en PubMed; PMID: 20071801.

  13. Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, Olson JJ. Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant Glioma. CA: A Cancer Journal for Clinicians. 2010;60(3):166-93. Citado en PubMed; PMID: 20445000.

  14. Grmec S, Mally S. Vasopressin improves outcome in out-of-hospital cardiopulmonary resuscitation of ventricular fibrillation and pulse less ventricular tachycardia: an observational cohort study. Crit Care. 2006 Feb;10(1):R13. Citado en PubMed; PMID: 16420660.

  15. Ray Swapan K. Glioblastoma: Molecular Mechanisms of Pathogenesis and Current Therapeutic Strategies. Springer; 2009.




2020     |     www.medigraphic.com